$PETS News

PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026

PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director

PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition

PetMeds Appoints Andrew Parry as Chief Technology Officer

PetMed Express (PETS) Q1 2027 Earnings Call Transcript

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...

PetMeds® Announces First Quarter Financial Results

PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript

Full Transcript: PetMed Express Q1 2027 Earnings Call

PetMed Express Q1 EPS $(0.28) Misses $0.12 Estimate, Sales $41.015M Beat $10.336M Estimate

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited

PetMed Express Board Confirms Proposed $3/Share Acquisition Offer From SilverCape Investments

Activist Investor Slams PetMed Board For 'Stunning Destruction' Of Shareholder Value

SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash